A case for immunization of human papillomavirus (HPV) 6/11-infected pregnant women with the quadrivalent HPV vaccine to prevent juvenile-onset laryngeal papilloma.
Shah, Keerti V.
J Infect Dis
; 209(9): 1307-9, 2014 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-24265442
Can quadrivalent human papillomavirus prophylactic vaccine be an effective alternative for the therapeutic management of genital warts? an exploratory study.
Detection of human papillomavirus in urine among heterosexual men in relation to location of genital warts and circumcision status.
Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe.
Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience.
Development of a human papillomavirus type 6/11 vaccine candidate for the prevention of condyloma acuminatum.
Fall in genital warts diagnoses in the general and indigenous Australian population following implementation of a national human papillomavirus vaccination program: analysis of routinely collected national hospital data.
Human papillomavirus typing in reporting of condyloma.
Association of varying number of doses of quadrivalent human papillomavirus vaccine with incidence of condyloma.
Modeling the impact of the difference in cross-protection data between a human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and a human papillomavirus (HPV)-6/11/16/18 vaccine in Canada.
Kondylome bei HIV-Infizierten.